Navigation Links
BioMarin Announces First Quarter 2011 Financial Results
Date:4/28/2011

eviously recognized) 1.8(1.7)3.5Total Aldurazyme net product revenues (5) $

18.7$

14.2$

4.5(4)  Changes in foreign currency rates caused an increase to Aldurazyme sales by Genzyme of $0.4 million in the three months ended March 31, 2011.  In the first quarter of 2011, the number of Aldurazyme vials shipped increased 6.4 percent over the first quarter of 2010.(5)  To the extent units shipped to third party customers by Genzyme exceed BioMarin inventory transfers to Genzyme, BioMarin records a decrease in net product revenue from the royalty payable to BioMarin for the amount of previously recognized product transfer revenue.  If BioMarin inventory transfers exceed units shipped to third party customers by Genzyme, BioMarin will record incremental net product transfer revenue for the period.2011 Guidance Revenue Guidance ($ in millions)

Item

2011 Guidance

Previous 2011 GuidanceTotal BioMarin Revenues

$422 to $452

$417 to $452Total Net Product Revenues

$416 to $446

$411 to $446Naglazyme Net Product Revenue

$211 to $225

$206 to $225Kuvan Net Product Revenue

Unchanged

$112 to $120Aldurazyme Net Product Revenue to BioMarin

Unchanged

$79 to $83Firdapse Net Product Revenue

Unchanged

$14 to $18Selected Income Statement Guidance ($ in millions)Item

2011 Guidance

Previous 2011 GuidanceCost of Sales (% of Total Revenue)

Unchanged

18% to 20%Selling, General and Admin. Expense

Unchanged

$164 to $174Research and Development Expense

Unchanged

$195 to $205Amortization and Contingent Consideration

Unchanged

$15Interest Income

Unchanged

$3Income Tax Expense (Benefit)

Unchanged

$15GAAP Net Income (Loss)

$(52) to $(42)

$(60) to $(48)Stock Compensation Expense

Unchanged

$43Non-GAAP Adjusted EBITDA

$51 to $61


'/>"/>
SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. BioMarin Announces FDA Approval for Kuvan
3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
8. BioMarin to Present at the Oppenheimer Healthcare Conference
9. BioMarin Announces Third Quarter 2009 Financial Results
10. BioMarin to Acquire LEAD Therapeutics
11. BioMarin to Present at the Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... -- Marta Rendon, MD, founder of the Rendon Center for Dermatology ... international key opinion leader in dermatology, was one of only ... to attend the international Aesthetic Experts Summit held ... at this gathering of over 600 physicians from 57 countries, ... experts from Asia and ...
(Date:11/24/2014)...  AiCure, an artificial intelligence company providing advanced ... ingestion, has announced the start of a major ... receiving medication as maintenance therapy for opioid addiction. ... have quadrupled in the last 15 years. Opioids ... cocaine and benzodiazepines combined. Overall, the economic cost ...
(Date:11/24/2014)... 2014  Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... the board of directors and from his positions as chairman ... recently serving as the company,s president and chief operating officer, ... the board of directors.  Gary Lyons , a member ... Mr. Gower is expected to remain an employee until the ...
Breaking Medicine Technology:Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3Can artificial intelligence solve the $55 billion problem of opioid abuse? 2Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3
... FRIMLEY, England, May 20 , - Tasigna(R) ... to Prior Treatment in the Chronic (Early) Phase ... Nature of Tasigna(R) Tackles the Root Cause of ... - Tasigna Expands CML Portfolio for Novartis, ...
... Similar to, Native Bladder by Six Months; Data Presented at May ... ... Session, ORLANDO, Fla. and EAST NORRITON, Pa., May 19 ... and neo-vessels, presented preclinical efficacy data for its,Tengion Neo-Bladder Replacement(TM) at ...
Cached Medicine Technology:Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 2Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 3Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 4Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 5Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM) 2
(Date:11/26/2014)... Obispo, CA (PRWEB) November 26, 2014 ... is offering lower prices in an early celebration of ... Bunion Booties are being offered at the promotional price ... promotional pricing is in addition to any automatic discounts ... the Bunion Bootie website for complete details. ...
(Date:11/26/2014)... News Facts , Lexmark’s ... RSNA 2014 in Chicago. The company will demonstrate ... images, photos, videos and documents found throughout the ... learn more about these innovative medical content management ... initiatives – that enable more informed clinical decisions, ...
(Date:11/26/2014)... -- Youngsters who enter puberty early are at increased ... puberty was linked with a number of factors associated ... levels, according to the researchers. Early puberty was also ... and peers, and having friends who were prone to ... study found an association between early puberty and these ...
(Date:11/26/2014)... -- The number of emergency department visits in the United ... record 136 million in 2011, according to the U.S. Centers ... that fewer people were going to ERs with non-urgent medical ... care within two hours of arriving at the ER. In ... Sixty percent of patients arrived at the ER after ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. 25, ... Nexium may disrupt the makeup of bacteria in the digestive ... a small new study suggests. The research doesn,t ... become ill, and study authors aren,t recommending that anyone stop ... "should be used at the lowest dose that provides adequate ...
Breaking Medicine News(10 mins):Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:ER Visits on the Rise, Study Reports 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 3
... in the pancreas, but in the brain as well. When ... can be brain cell death and subsequent development of the ... was conducted in rats, and it was identified that insulin ... produced in the nerve cells, neurons in several brain regions. ...
... of the International Association for Dental Research held in ... a study// that says eating sugar-free yogurt is good ... odor or so called bad breath is caused by ... study revealed that volunteers who had sugar-free more and ...
... in the juice of pomegranate may help in reducing ... process of plaques etc forming in the inner lining ... state of atherosclerosis. This causes disturbed blood flow and ... the risk of atherogenesis. ,The new study ...
... has found out that depression has to be blamed for ... to treat the same. The study was conducted on 60,000 ... results showed both the newer and older classes of antidepressants ... first month of being prescribed.The older class of tricyclic antidepressants ...
... Diabetes Care, March 2005, scientists have reported that caffeine may ... the measure for the risk of heart disease. If a ... risk of heart problems. ,Diabetes type 2 happens when ... As this happens the body becomes unable to produce enough ...
... administration of the drug tezosentan did not improve worsening heart ... // despite high hopes. The above fact was found out ... date. The study was conducted to evaluate if something more ... to speed up hospital discharge and prevent them from coming ...
Cached Medicine News:
... Helmer PC1200 Platelet Incubators ... your laboratory counter top. These ... institution to have the security ... environment without taking up a ...
The PC4200i is the largest capacity platelet incubator available. It features a built-in agitator with a capacity of 396 random bags (132 apheresis)....
... Platelet incubators hold rotators and ... temperature can be set at ... 15C to 40C (59F to ... from top to bottom. Recorder ...
An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Medicine Products: